Merck

Lawsuit stalls approval of Merck’s insulin injection
Drug Delivery Business News
Thu, 07/20/17 - 06:08 pm
Merck
insulin
diabetes
Lusduna Nexvue
Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending
Fierce Pharma
Mon, 07/17/17 - 06:49 pm
Merck
Keytruda
drug pricing
non-small cell lung cancer
The top 15 highest-paid biopharma executives
Fierce Pharma
Fri, 07/14/17 - 08:42 am
executive pay
Mylan Labs
Valeant Pharmaceuticals
Medivation
Regeneron
JNJ
Merck
5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings
Yahoo/Zacks.com
Thu, 07/13/17 - 09:49 am
earnings
Merck
Eli Lilly
Celgene
Gilead Sciences
Shire
FDA Considers Label Changes for Keytruda, Opdivo and Yervoy
RAPS.org
Wed, 07/12/17 - 02:41 pm
FDA
labeling
Keytruda
Opdivo
Yervoy
immuno-oncology
Merck
Bristol-Myers Squibb
HPV Infection Rates Plummet With Vaccination
Forbes
Tue, 07/11/17 - 11:59 pm
HPV
vaccines
cervical cancer
Gardasil
Merck
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
What the FDA's Hold on Three Merck Studies Means for Other Drug Makers
TheStreet.com
Sun, 07/9/17 - 07:44 pm
Merck
Keytruda
FDA
clinical trials
Multiple Myeloma
Bristol-Myers Squibb
AstraZeneca
Celgene
Prescribed Reading: I/O is the only game in town
BioPharma Dive
Sat, 07/8/17 - 10:02 am
immuno-oncology
Celgene
BeiGene
Endo International
Opana ER
Novartis
Orkambi
Vertex Pharmaceuticals
Merck
Bristol-Myers Squibb
Roche
Opdivo
Keytruda
Orencia
Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
Endpoints
Wed, 07/5/17 - 07:06 pm
FDA
Merck
Keytruda
clinical trials
Multiple Myeloma
Personalized cancer vaccines vanquish melanoma in small but encouraging study
Stat
Wed, 07/5/17 - 07:04 pm
personalized medicine
cancer
vaccines
melanoma
Keytruda
Merck
Neon Therapeutics
Can Merck knock Glaxo off its HIV perch? Maybe so, one analyst says
Fierce Pharma
Wed, 07/5/17 - 07:02 pm
Merck
GSK
HIV
ViiV
EFdA
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Merck left the door open to a devastating cyberattack, missing two chances to raise a defense
Endpoints
Fri, 06/30/17 - 10:58 am
Merck
cybersecurity
Merck targeted in global ransomware attack
Fierce Pharma
Tue, 06/27/17 - 11:55 pm
Merck
ransomware
cybersecurity
Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed
Forbes
Tue, 06/27/17 - 11:01 am
Merck
Anacetrapib
cholesterol
clinical trials
Little Alder bags positive PhIII migraine data, but giant rivals are racing ahead in a crowded field
Endpoints
Tue, 06/27/17 - 09:38 am
Alder Biopharma
migraines
clinical trials
eptinezumab
Eli Lilly
Amgen
Novartis
Merck
The FDA Has Never Approved a Drug Like This in Its 111-Year History
Motley Fool
Sun, 06/25/17 - 10:50 am
FDA
Merck
Keytruda
mismatch repair deficiency
Could Merck and Leap union be the one for Keytruda?
TheStreet.com
Sat, 06/24/17 - 09:28 am
Merck
Leap Therapeutics
Keytruda
antibodies
DKN-01
esophagogastric cancer
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer
Xconomy
Fri, 06/16/17 - 09:28 am
Checkmate Pharmaceuticals
melanoma
Keytruda
Merck

Pages